Medical Technology and Evaluation Coursera Assessment Week-wise Answer [Updated Answers‼️] 2021

Hello Peers, Today we are going to share all week assessment and quizzes answers of Medical Technology and Evaluation course launched by Coursera for totally free of cost✅✅✅. This is a certification course for every interested students.

In case you didn’t find this course for free, then you can apply for financial ads to get this course for totally free.

Checkout this article for“How to Apply for Financial Ads?”

Coursera, a India’s biggest learning platform which launched millions of free courses for students daily. These courses are from various recognized university, where industry experts and professors teaches in a very well manner and in a more understandable way.

Here, you will find Medical Technology and Evaluation Exam Answers in Bold Color which are given below.

These answers are updated recently and are 100% correctanswers of all week, assessment and final exam answers of Medical Technology and Evaluation from Coursera Free Certification Course.

Use “Ctrl+F” To Find Any Questions Answer. & For Mobile User, You Just Need To Click On Three dots In Your Browser & You Will Get A “Find” Option There. Use These Option to Get Any Random Questions Answer.

Apply Link – Medical Technology and Evaluation

Medical Technology and Evaluation Answer

Week- 1

Medical Technology Assessment Environment

1.
Question 1
Which of the following is a use a potential user of medical technology evaluation results?

1 point

  • Manufacturers.
  • Insurers.
  • Health care providers.
  • All of the above.

2.
Question 2
True or False: A medical technology evaluation is just a pricing project.

1 point

  • True
  • False

3.
Question 3
How can a new technology with lower costs lead to higher health care expenditures?

1 point

  • The technology will only reduce expenditures.
  • The technology is effective and used by a larger population than the current technology.
  • No new technologies have lower costs.
  • The technology has better outcomes compared to the current technology.

4.
Question 4
What is the regulatory reason that medical technology evaluation evidence is needed?

1 point

  • Only payment/reimbursement.
  • Venture capitalist investments.
  • Pricing.
  • Marketing approval and payment/reimbursement.

5.
Question 5
Which of the FDA approval phases occurs after FDA approval?

1 point

  • Phase IV
  • Phase III and IV
  • None
  • Phase I

6.
Question 6
True or False: Once approved a new drug can only be prescribed for what it was approved to treat.

1 point

  • True
  • False

7.
Question 7
Approximately what percent of new medical devices require a Pre-Market Approval (PMA)?

1 point

  • 0 percent
  • 100 percent
  • 90 percent
  • 10 percent

8.
Question 8
What is the next step after a drug is approved by the FDA?

1 point

  • File an NDA.
  • Conduct a clinical trial.
  • Get insurers to pay/reimburse.
  • Design the packaging.

9.
Question 9
What aspects of medical care is covered by Medicare Part A?

1 point

  • Outpatient services.
  • Inpatient hospital care.
  • Prescription drugs.
  • Patient out-of-pocket costs.

10.
Question 10
True or False: Patients may have higher cost sharing obligations for the more expensive brand name version of a drug.

1 point

  • True
  • False

Week- 2

Clinical Trials and Insurance Claims Data
  1. following is an example of an experimental design?

1 point

  • Patient survey
  • Case study
  • Observational study
  • Randomized controlled trial

2.
Question 2

Which
of the following is not an alternative to randomization?

1 point

  • A placebo treatment.
  • Historical controls.
  • Systematic alternation of treatments.
  • Non-randomized concurrent controls.

3.
Question 3
Who is “blinded” in a double blind trial design?

1 point

  • Patient and Investigator/Provider
  • Investigator/Provider and Statistician
  • Patient and Caregiver
  • Patient and Statistician

4.
Question 4

Which
of the following elements is included in claims data?

1 point

  • Diagnoses and procedure codes.
  • Procedure codes and prices.
  • Prices and patient demographics.
  • All of the above.

5.
Question 5

Which of the following is not a benefit of claims
data?

1 point

  • Includes physicians’ notes.
  • Large samples.
  • Includes all sources of care.
  • Diagnoses and procedures.

6.
Question 6
What are DRGs used for?

1 point

  • FDA approval.
  • Medicare inpatient billing/payment.
  • Measuring QALYs.
  • Prescription drug reimbursement.

7.
Question 7

What
population is covered by Medicare?

1 point

  • Ages 65 and older and disabledThe working population
  • Anyone
  • None of the above

8.
Question 8

Which
of the following is not a potential source of bias?

1 point

  • Currency
  • Reporting
  • Detection
  • Selection

9.
Question 9

Which
of the following questions can a meta-analysis answer?

1 point

  • What is the direction of the effect?
  • What is the size of the effect?
  • Is the effect consistent across studies?
  • All of the above

10.
Question 10

True or False: claims data can only be used for policy
research.

1 point

  • True
  • False

Week- 3

Peer-graded Assignment: You Are The Consultant

Download

Week- 4

Methodological Approaches and Considerations

1.
Question 1

If
an assessment is being conducted to support the case for payment/reimbursement
who is the audience?

1 point

  • The Food and Drug Administration (FDA)
  • Physicians
  • Insurers or Payers
  • Venture capitalists

2.
Question 2

What is the denominator of the incremental cost effectiveness ratio (ICER)?

1 point

  • Indirect costs.
  • Future costs.
  • Benefits of the new technology.
  • Difference in benefits.

3.
Question 3
True or False: Only cost effective technologies ICERs can be graphed on the cost effectiveness plane.

1 point

  • True
  • False

4.
Question 4

What is Bayes’
rule used for?

1 point

  • Measuring quality of life (QoL).
  • Randomization in a clinical trial.
  • Incorporating new information to determine a probability of interest.
  • Graph an ICER.

5.
Question 5

Future values of which
of the following can be discounted to present value?

1 point

  • Direct medical costs.
  • Indirect costs.
  • Quality adjusted life years (QALYs).
  • All of the above.

6.
Question 6

The
expected value of a health outcome is calculated by multiplying the outcome measure by what?

1 point

  • Quality of Life (QoL).
  • The discount rate.
  • Direct costs.
  • The probability of the outcome.

7.
Question 7

The
results of a Monte Carlo simulation can be used to determine the what information about the results of an evaluation?

1 point

  • Mean and variance of the results.
  • The mean result.
  • The variance of the result.
  • None of the above.

8.
Question 8

True or False: A Markov model allows for modeling the progression
of disease over time.

1 point

  • True
  • False

9.
Question 9

Which
of the following is not a source of uncertainty?

1 point

  • Future costs.
  • Randomness in medical cost.
  • Randomness in health outcomes.
  • Statistical variation in results.

10.
Question 10

In
a sensitivity analysis how many variables can be tested?

1 point

  • Only one
  • None
  • One or more
  • Only two

Conclusion

Hopefully, this article will be useful for you to find all the Week, final assessment and Peer Graded Assessment Answers of Medical Technology and Evaluation of Coursera and grab some premium knowledge with less effort. If this article really helped you in any way then make sure to share it with your friends on social media and let them also know about this amazing training. You can also check out our other course Answers. So, be with us guys we will share a lot more free courses and their exam/quiz solutions also and follow our Techno-RJ Blog for more updates.

Leave a Comment

Ads Blocker Image Powered by Code Help Pro
Ads Blocker Detected!!!

We have detected that you are using extensions to block ads. Please support us by disabling these ads blocker.

Refresh